missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Trametinib

Artikelnummer. 18746376
Ansicht ändern
Click to view available options
Menge:
10 mg
50 mg
Packungsgröße:
10 Milligramm
50 Milligramm
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Menge Packungsgröße
18746376 10 mg 10 Milligramm
18755836 50 mg 50 Milligramm
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen
Artikelnummer. 18746376 Lieferant R&D Systems™ Lieferanten-Nr. 7709/10
  • ONLINE EXCLUSIVE PRICE
    181.21 CHF
    163.80 CHF / 10 Milligramm
    Sparen 17.41 CHF
    9% Rabatt
 Eingeschränkter Artikel
Verfügbar ab: 19-11-2026
Zum Warenkorb hinzufügen
Add to basket

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

A Tocris product, part of R&D Systems. Potent and selective MEK inhibitor; orally bioavailable

Trametinib is a potent and selective MEK1 and MEK2 inhibitor (IC50 = 0.92 and 1.8 nM, respectively, in cell-free assays). In vitro, it inhibits the growth of human colorectal cancer cell lines expressing either B-RAF or K-RAF (IC50 values range from 0.48 to 36 nM). In vivo, it suppresses tumor growth of HT-29 and COLO205 xenografts in nude mice. Trametinib induces apoptosis. This compound is orally bioavailable.
TRUSTED_SUSTAINABILITY

Specifications

Chemischer Name oder Material N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2 H)-yl]phenyl]acetamide
CAS 871700-17-3
Menge 10 mg
Produktlinie Tocris
Ziel MEK Inhibitors
Summenformel C26H23FIN5O4
Reinheit 0.98
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.